Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2024-03-26 00:00:00 ET · period of report 2024-03-26 · accession 0001453687-24-000045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-03-26 | 2024-03-26 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | $1.46 | +1.97M | 33.04M | +6% | +$2.88M |
| DI | 2024-03-26 | 2024-03-26 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | $0.00 | -1.97M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-26 | M | A | 1,970,443 | $1.46 | 33,043,849 | I See Footnote | — | — | (F1) Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any. |
| 2 | Derivative | Warrant (Right to Buy) | 2024-03-26 | M | D | 1,970,443 | $0.00 | 0 | I See Footnote | $1.46 · 2019-12-23 to 2024-12-23 | 1,970,443 Common Stock | (F1) Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any. |